OAM
CLBT icon

Oberweis Asset Management’s Cellebrite CLBT Stock Holding History

Oberweis Asset Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-414,550
Closed -$7.68M – 186
2025
Q3 		$7.68M Buy
414,550
+18,580
+5% +$292K 0.29% 121
2025
Q2 		$6.34M Sell
395,970
-296,940
-43% -$5.29M 0.28% 127
2025
Q1 		$13.5M Hold
692,910
– – 0.67% 57
2024
Q4 		$15.3M Buy
692,910
+8,100
+1% +$156K 0.72% 49
2024
Q3 		$11.5M Buy
684,810
+81,210
+13% +$1.21M 0.59% 61
2024
Q2 		$7.21M Buy
603,600
+205,700
+52% +$2.3M 0.44% 84
2024
Q1 		$4.41M Buy
+397,900
New +$4.06M 0.32% 119

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Oberweis Asset Management's CLBT Position: Q4 2025 in Review

Oberweis Asset Management sold out of Cellebrite (CLBT) in Q4 2025, closing a stake of 414,550 shares — an estimated $7.68M sold.

Oberweis Asset Management first reported a position in CLBT in Q1 2024 and held it in 7 quarters. The position peaked at $15.3M in Q4 2024. 208 funds tracked by Wall St. Rank hold CLBT as of Q4 2025.

  • Oberweis Asset Management reported no remaining Cellebrite position as of Q4 2025 after selling out during the quarter.
  • Oberweis Asset Management sold 414,550 Cellebrite shares in Q4 2025, an estimated $7.68M.
  • Oberweis Asset Management first reported a position in Cellebrite in Q1 2024 and held it in 7 quarters.
  • Oberweis Asset Management's Cellebrite position peaked at $15.3M in Q4 2024.
  • 208 funds tracked by Wall St. Rank held Cellebrite as of Q4 2025.

Based on Oberweis Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.